The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Observational Studies Analyzed Like Randomized Experiments: An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease
Open accessAbstract
BACKGROUND: The Women's Health Initiative randomized trial found greater coronary heart disease (CHD) risk in women assigned to estrogen/progestin therapy than in those assigned to placebo. Observational studies had previously suggested reduced CHD risk in hormone users. METHODS: Using data from the observational Nurses' Health Study, we emulated the design and intention-to-treat (ITT) analysis of the randomized trial. The observational study was conceptualized as a sequence of "trials," in which eligible women were classified as initiators or noninitiators of estrogen/progestin therapy. RESULTS: The ITT hazard ratios (HRs) (95% confidence intervals) of CHD for initiators versus noninitiators were 1.42 (0.92-2.20) for the first 2 years, and 0.96 (0.78-1.18) for the entire follow-up. The ITT HRs were 0.84 (0.61-1.14) in women within 10 years of menopause, and 1.12 (0.84-1.48) in the others (P value for interaction = 0.08). These ITT estimates are similar to those from the Women's Health Initiative. Because the ITT approach causes severe treatment misclassification, we also estimated adherence-adjusted effects by inverse probability weighting. The HRs were 1.61 (0.97-2.66) for the first 2 years, and 0.98 (0.66-1.49) for the entire follow-up. The HRs were 0.54 (0.19-1.51) in women within 10 years after menopause, and 1.20 (0.78-1.84) in others (P value for interaction = 0.01). We also present comparisons between these estimates and previously reported Nurses' Health Study estimates. CONCLUSIONS: Our findings suggest that the discrepancies between the Women's Health Initiative and Nurses' Health Study ITT estimates could be largely explained by differences in the distribution of time since menopause and length of follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563
Miller, R. G. (1981) · Cited by 3,336
A structural approach to selection bias
Hernán, M. A., Hernández-Díaz, S., & Robins, J. M. (2004) · Epidemiology · doi:10.1097/01.ede.0000135174.63482.43 · Cited by 2,844 · cited 1×
“of their estimated probability of remaining uncensored until that month.(16) To estimate “trial”-specific probabilities for each woman, we fit a pooled logistic model for the probability of remaining on the baseline treatment through a given month.”
BackgroundSelf-citationDesign of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Robins, J. (1986) · Mathematical Modelling · doi:10.1016/0270-0255(86)90088-6 · Cited by 2,451
Self-citationA comparison of observational studies and randomized, controlled trials.
Benson, K., & Hartz, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422506 · Cited by 2,347
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065 · cited 1×
“6 years).(8,9) The present paper does not address the complex clinical and public health issues related to hormone therapy, including risk-benefit considerations.”
BackgroundSelf-citationPrimary Prevention of Coronary Heart Disease in Women through Diet and Lifestyle
Stampfer, M. J., Hu, F. B., Manson, J. E., Rimm, E. B., & Willett, W. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430103 · Cited by 1,794
Self-citationEvaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646
Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
Grodstein, F., Stampfer, M. J., Manson, J. E., Colditz, G. A., Willett, W. C., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350701 · Cited by 1,305
Self-citationGrodstein, F., Manson, J. E., Colditz, G. A., Willett, W. C., Speizer, F. E., & Stampfer, M. J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00008 · Cited by 1,063
Self-citationComparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
Ioannidis, J. P. A. (2001) · JAMA · doi:10.1001/jama.286.7.821 · Cited by 919
Holm, J. C., Nowicka, P., Farpour-Lambert, N. J., O'Malley, G., Hassapidou, M., Weiss, R., & Baker, J. L. (2014) · Obesity Facts · doi:10.1159/000365773 · Cited by 592
Grodstein, F., Manson, J. E., & Stampfer, M. J. (2006) · Journal of Women's Health · doi:10.1089/jwh.2006.15.35 · Cited by 479
Self-citationA comparison of observational studies and randomized, controlled trials
Benson, K., & Hartz, A. J. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(00)00754-6 · Cited by 457
KEEPS: The Kronos Early Estrogen Prevention Study
Harman, S., Brinton, E., Cedars, M., Lobo, R., Manson, J., Merriam, G., Miller, V., Naftolin, F., & Santoro, N. (2005) · Climacteric · doi:10.1080/13697130500042417 · Cited by 397
Self-citationRobins, J. M., Blevins, D., Ritter, G., & Wulfsohn, M. (1992) · Epidemiology · doi:10.1097/00001648-199207000-00007 · Cited by 334
Self-citationUnderstanding the Divergent Data on Postmenopausal Hormone Therapy
Grodstein, F., Clarkson, T. B., & Manson, J. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmsb022365 · Cited by 329
Self-citationPrentice, R. L., Langer, R., Stefanick, M. L., Howard, B. V., Pettinger, M., Anderson, G., Barad, D., Curb, J. D., Kotchen, J., Kuller, L., et al. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi223 · Cited by 264
Robins, J. M. (1987) · Computers & Mathematics with Applications · doi:10.1016/0898-1221(87)90238-0 · Cited by 212
Self-citationHernán, M. A., Cole, S. R., Margolick, J., Cohen, M., & Robins, J. M. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1064 · Cited by 169
Self-citationGout and risk of Parkinson disease: A prospective study
Alonso, A., Rodríguez, L. A. G., Logroscino, G., & Hernán, M. A. (2007) · Neurology · doi:10.1212/01.wnl.0000279518.10072.df · Cited by 166
Self-citationHormone Replacement Therapy and Incidence of Acute Myocardial Infarction
Varas‐Lorenzo, C., García‐Rodríguez, L. A., Perez‐Gutthann, S., & Oliart, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.22.2572 · Cited by 150
Mark, S. D., & Robins, J. M. (1993) · Controlled Clinical Trials · doi:10.1016/0197-2456(93)90012-3 · Cited by 146
Self-citationMendelsohn, M. E., & Karas, R. H. (2007) · New England Journal of Medicine · doi:10.1056/nejme078072 · Cited by 137
Statistical Issues Arising in the Women's Health Initiative
Prentice, R. L., Pettinger, M. B., & Anderson, G. L. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.454_1.x · Cited by 109
Manson, J. E., & Bassuk, S. S. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm213 · Cited by 78
Self-citationStructural Nested Failure Time Models
Robins, J. M. (2014) · Wiley eBooks · doi:10.1002/9781118445112.stat06059 · Cited by 75
Self-citationPrincipal Stratification Designs to Estimate Input Data Missing Due to Death
Frangakis, C., Rubin, D. B., An, M., & MacKenzie, E. J. (2007) · Biometrics · doi:10.1111/j.1541-0420.2007.00847_1.x · Cited by 61
Connelly, M. T., Richardson, M. K., & Platt, R. G. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.03499.x · Cited by 38
Discussion on "Statistical Issues Arising in the Women's Health Initiative"
Hernán, M. Á., Robins, J. M., & Rodríguez, L. A. G. (2005) · Biometrics · doi:10.1111/j.0006-341x.2005.454_7.x · Cited by 35
Self-citationEffect of acyclovir on herpetic ocular recurrence using a structural nested model
Cole, S. R., & Chu, H. (2005) · Contemporary Clinical Trials · doi:10.1016/j.cct.2005.01.009 · Cited by 28
Robins, J. M., Rotnitzky, A. G., & Vansteelandt, S. (2007) · Biometrics · doi:10.1111/j.1541-0420.2007.00847_2.x · Cited by 25
Self-citation
Cited by
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
“18 However, fear that evidence from NRSI may be biased, based on misleading results of some NRSI, 19 20 has led to caution in their use in making judgements about efficacy.”
BackgroundSelf-citationUsing Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
Hernán, M. A., & Robins, J. M. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv254 · Cited by 3,115
Self-citationInterpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857
Hernán, M. A. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c1ea43 · Cited by 1,370
Self-citationTriangulation in aetiological epidemiology
Lawlor, D. A., Tilling, K., & Davey Smith, G. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyw314 · Cited by 1,129
Metadata
- Authors
- Hernán, M. A., Alonso, A., Logan, R., Grodstein, F., Michels, K. B., Willett, W. C., Manson, J. E., & Robins, J. M.
- Venue
- Epidemiology
- Published
- 2008-11
- Volume
- 19
- Issue
- 6
- Pages
- 766-779
- ISSN
- 1044-3983 (ISSN-L)
- OpenAlex
- W2062359643
- Cited by
- 818
- References
- 33
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.